{"result": "{\n    \"title\": \"Drotrecogin Alfa Activated and Severe Sepsis Treatment Community\",\n    \"summary\": \"This community centers around the clinical application and study of Drotrecogin Alfa Activated in the treatment of severe sepsis, involving key entities such as Activated Protein C, Covance Central Lab Services, and various clinical research tools and methodologies. The relationships highlight the drug's impact on patient outcomes, its comparison to placebo, and the role of specific biomarkers and tests in evaluating its efficacy.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of severe sepsis treatment and the significant role of Drotrecogin Alfa Activated in potentially reducing mortality rates.\",\n    \"findings\": [\n        {\n            \"summary\": \"Drotrecogin Alfa Activated's role in severe sepsis treatment\",\n            \"explanation\": \"Drotrecogin Alfa Activated is central to this community, with its use in treating severe sepsis highlighted by its anti-inflammatory and antithrombotic activities. Clinical trials have demonstrated its efficacy in reducing mortality rates among severe sepsis patients, underscoring its importance in critical care medicine. The drug's administration and its comparison to a placebo group form the basis of its evaluation in the clinical setting. [Data: Entities (173), Relationships (303, 146, 116)]\"\n        },\n        {\n            \"summary\": \"Activated Protein C's significance\",\n            \"explanation\": \"Activated Protein C, mimicked by Drotrecogin Alfa Activated, plays a pivotal role in the community due to its anti-inflammatory properties and its impact on neutrophil activation and cytokine production. Its involvement in clinical trials, especially those targeting septic shock, positions it as a key factor in understanding the treatment's mechanisms and effectiveness. [Data: Entities (185), Relationships (74, 424)]\"\n        },\n        {\n            \"summary\": \"Covance Central Lab Services' contribution\",\n            \"explanation\": \"Covance Central Lab Services in Indianapolis is instrumental in assaying blood samples for D-dimer and interleukin-6 levels, crucial biomarkers in the study of Drotrecogin Alfa Activated's efficacy. Their role emphasizes the importance of accurate and reliable laboratory data in clinical research, facilitating the assessment of the drug's impact on inflammation and coagulation. [Data: Entities (175), Relationships (418, 426, 427)]\"\n        },\n        {\n            \"summary\": \"The impact of Drotrecogin Alfa Activated on biomarkers\",\n            \"explanation\": \"Drotrecogin Alfa Activated's effectiveness is partly measured by its impact on key biomarkers, including D-dimer and interleukin-6 levels. Lower levels of these markers in treated patients compared to the placebo group highlight the drug's anti-inflammatory and antithrombotic effects, providing evidence for its clinical utility in severe sepsis management. [Data: Entities (183, 184), Relationships (422, 423)]\"\n        },\n        {\n            \"summary\": \"Adverse events associated with Drotrecogin Alfa Activated\",\n            \"explanation\": \"While Drotrecogin Alfa Activated shows promise in severe sepsis treatment, it is also associated with an increased risk of serious bleeding, particularly in predisposed patients. This adverse event underscores the need for careful patient selection and monitoring during treatment, balancing the drug's benefits against its potential risks. [Data: Entities (187), Relationships (425)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n185,ACTIVATED PROTEIN C,\"Activated Protein C is recognized for its anti-inflammatory properties, which include the inhibition of neutrophil activation and cytokine production. These properties are effectively mimicked by drotrecogin alfa activated. Its frequent use in clinical trials, particularly those investigating treatments for septic shock, has the potential to influence the outcomes and interpretation of the treatment's effectiveness. This highlights the significant role Activated Protein C plays in medical research and its impact on understanding and treating conditions like septic shock.\",2\n173,DROTRECOGIN ALFA ACTIVATED,\"Drotrecogin alfa (activated) is a medication specifically used in the treatment of severe sepsis. It is known for its anti-inflammatory and antithrombotic activities, which contribute to a reduction in mortality rates and inflammation markers in patients with severe sepsis. The drug is administered intravenously at a dose of 24 μg per kilogram of body weight per hour, over a total duration of 96 hours. Its efficacy in treating severe sepsis has been the subject of clinical trials, further establishing its role in managing this critical condition.\",12\n175,\"COVANCE CENTRAL LAB SERVICES, INDIANAPOLIS\",The central laboratory responsible for assaying blood samples for D-dimer and interleukin-6 levels during the study,4\n179,COCHRAN–MANTEL–HAENSZEL TEST,No Description,1\n183,D-DIMER,A marker of coagulation that was significantly lower in patients treated with drotrecogin alfa activated compared to the placebo group,1\n182,PROTEIN C DEFICIENCY,\"A condition that was a focus in the subgroup analyses of the study, related to the effectiveness of drotrecogin alfa activated\",1\n184,INTERLEUKIN-6,\"Interleukin-6 is a cytokine that plays a significant role in inflammation. It serves as an inflammation marker, with its levels being indicative of inflammatory activity within the body. Research has shown that treatment with drotrecogin alfa activated leads to a decrease in Interleukin-6 levels, highlighting the treatment's anti-inflammatory effects. This decrease was more pronounced in individuals receiving drotrecogin alfa activated compared to those in the placebo group, further underscoring the effectiveness of drotrecogin alfa activated in reducing inflammation through the modulation of Interleukin-6 levels.\",1\n187,SERIOUS BLEEDING,\"The most common adverse event associated with drotrecogin alfa activated, occurring in predisposed patients and indicative of its antithrombotic activity\",1\n177,\"DIAGNOSTICA STAGO, ASNIERES, FRANCE\",The manufacturer of the Liatest D-D1 latex agglutination test kit used for D-dimer level assays in the study,1\n178,\"R & D SYSTEMS, MINNEAPOLIS\",The manufacturer of the Quantikine HS enzyme immunoassay kit used for interleukin-6 level assays in the study,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n74,SEPTIC SHOCK,ACTIVATED PROTEIN C,\"The use of activated protein C in the trial indicates its significance in the treatment regimen for septic shock, impacting the interpretation of treatment outcomes\",79\n146,PLACEBO GROUP,DROTRECOGIN ALFA ACTIVATED,\"The clinical trial focused on comparing the efficacy of Drotrecogin Alfa Activated with that of a placebo in treating patients with severe sepsis. Both descriptions highlight the same comparison between the effects of Drotrecogin Alfa Activated and a placebo group, underscoring the study's aim to evaluate the treatment's effectiveness in severe sepsis cases.\",35\n303,SEVERE SEPSIS,DROTRECOGIN ALFA ACTIVATED,\"Drotrecogin Alfa Activated has been tested for its effectiveness in treating severe sepsis, demonstrating a significant reduction in mortality rates among patients. This treatment is specifically associated with improving outcomes in those suffering from severe sepsis, indicating its potential as a beneficial therapeutic option. The consistent findings across studies highlight Drotrecogin Alfa Activated's role in reducing the mortality rates in severe sepsis patients, underscoring its importance in the management of this critical condition.\",34\n116,PLACEBO,DROTRECOGIN ALFA ACTIVATED,Patients who received drotrecogin alfa activated showed greater decreases in D-dimer and interleukin-6 levels than those who received placebo,30\n115,PLACEBO,\"COVANCE CENTRAL LAB SERVICES, INDIANAPOLIS\",\"Covance Central Lab Services, Indianapolis, performed blood assays to measure the effects of placebo\",22\n418,DROTRECOGIN ALFA ACTIVATED,\"COVANCE CENTRAL LAB SERVICES, INDIANAPOLIS\",\"Covance Central Lab Services, Indianapolis, performed blood assays to measure the effects of drotrecogin alfa activated\",16\n420,DROTRECOGIN ALFA ACTIVATED,ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II (APACHE II),APACHE II scores were used to stratify patients receiving drotrecogin alfa activated based on the severity of their disease,15\n424,DROTRECOGIN ALFA ACTIVATED,ACTIVATED PROTEIN C,Drotrecogin alfa activated mimics the antiinflammatory properties of activated protein C,14\n417,DROTRECOGIN ALFA ACTIVATED,CENTRAL RANDOMIZATION CENTER,Drotrecogin alfa activated was assigned to patients through the Central Randomization Center as part of the study's treatment protocol,14\n419,DROTRECOGIN ALFA ACTIVATED,COCHRAN–MANTEL–HAENSZEL TEST,The Cochran–Mantel–Haenszel test was used to analyze the treatment effect of drotrecogin alfa activated compared to placebo,13\n422,DROTRECOGIN ALFA ACTIVATED,D-DIMER,Patients treated with drotrecogin alfa activated had significantly lower D-Dimer levels compared to those in the placebo group,13\n421,DROTRECOGIN ALFA ACTIVATED,PROTEIN C DEFICIENCY,The study analyzed the effect of drotrecogin alfa activated on patients with and without protein C deficiency,13\n423,DROTRECOGIN ALFA ACTIVATED,INTERLEUKIN-6,\"Drotrecogin alfa activated is a treatment that has been shown to significantly decrease interleukin-6 levels in patients. This reduction in interleukin-6 levels indicates drotrecogin alfa activated's anti-inflammatory activity. By lowering the levels of interleukin-6, a key marker of inflammation, drotrecogin alfa activated demonstrates its effectiveness in managing conditions associated with elevated levels of this cytokine.\",13\n425,DROTRECOGIN ALFA ACTIVATED,SERIOUS BLEEDING,\"The administration of drotrecogin alfa activated is associated with an increased incidence of serious bleeding, especially in predisposed patients\",13\n426,\"COVANCE CENTRAL LAB SERVICES, INDIANAPOLIS\",\"DIAGNOSTICA STAGO, ASNIERES, FRANCE\",Diagnostica Stago provided the test kits used by Covance Central Lab Services for D-dimer assays,5\n427,\"COVANCE CENTRAL LAB SERVICES, INDIANAPOLIS\",\"R & D SYSTEMS, MINNEAPOLIS\",R & D Systems provided the test kits used by Covance Central Lab Services for interleukin-6 assays,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}